Michael D. Fox, MD, PhD, Receives American Neurological Association Award for Outstanding Accomplishment in Academic Neurology
Jacqueline Mitchell (BIDMC Communications) 617-667-7306, email@example.com
AUGUST 22, 2019
Michael D. Fox, MD, PhD, Director of the Laboratory for Brain Network Imaging and Modulation at Beth Israel Deaconess Medical Center (BIDMC), Co-Director of the BIDMC Deep Brain Stimulation Program and Associate Director of the Berenson-Allen Center for Noninvasive Brain Stimulation, has been awarded the 2019 Derek Denny-Brown Young Neurological Scholar Award in Basic Science by the American Neurological Association (ANA). Awarded each year to ANA members who have achieved significant stature in neurological research, who show promise and who will continue making major contributions to the field of neurology, the Derek Denny-Brown Young award is given in recognition of Fox’s work mapping and treating neuropsychiatric symptoms using a technique he pioneered known as lesion network mapping.
Lesion network mapping leverages brain connectivity information housed in a publicly-available database called the Human Connectome to discover the brain regions connected to brain lesions – areas of the brain that appear abnormal in brain imaging tests. Fox and colleagues have successfully used the method to reveal which parts of the brain are responsible for hallucinations, delusions, involuntary movements, coma, criminal behavior, and – in perhaps its most philosophical application to date – free will.
A practicing clinical neurologist at BIDMC since 2014, Fox – who is also Associate Professor of Neurology at Harvard Medical School – specializes in the use of both invasive and noninvasive brain stimulation for the treatment of neurological disease. His clinical practice includes deep brain stimulation (DBS) for the treatment of Parkinson’s disease, essential tremor, and dystonia as well as transcranial magnetic stimulation (TMS) for treatment of medication-refractory depression.
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding.
BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Rehabilitation Center and is a research partner of Dana-Farber/Harvard Cancer Center and the Jackson Laboratory. BIDMC is the official hospital of the Boston Red Sox. For more information, visit www.bidmc.org.
BIDMC is part of Beth Israel Lahey Health, a new health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,000 physicians and 35,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.